Frankfurt/Main, 19.06.2024 – Funds advised by PINOVA Capital GmbH have acquired a majority stake in the Neuromedex Group, in a transaction that sees Neuromedex’s founder and another director reinvesting in the company.
Hamburg-based Neuromedex is a leading supplier of single-use products for neurosurgery and intensive care medicine. Neuromedex products enable neurosurgeons to monitor and regulate intracranial pressure in their patients’ brains with minimal infection risk. PINOVA’s investment will mainly be used to drive the go-to-market of new innovative products and expansion of the international sales network.
A CMS team led by partner Markus Herz advised PINOVA on all legal aspects of the transaction. PINOVA regularly relies on the expertise of CMS teams, including during the recent acquisition of Riepe GmbH & Co. KG.
CMS Germany
Markus Herz, Lead Partner
Hanno Brandt, Senior Associate
Lorenz Liebsch, Senior Associate
Maxine Notstain, Senior Associate, all Corporate/M&A
Philippe Heinzke, Partner
Thomas Fröhlich, Counsel
Lisa Dietrich, Associate
Sara Kapur, Associate, all TMC
Dr Mario Brungs, Counsel, Labor, Employment & Pensions
Birgit Wagner, Legal Manager
Julian Buhr, Legal Coordinator
Conrad Gräwe, Legal Coordinator
Shae Lynn Washington, Legal Coordinator
Tagrid Chahrour, Senior Legal Specialist
Anke Clippingdale, Senior Legal Specialist, all Smart Operations
Press Contact
presse@cms-hs.com
